This HTML5 document contains 164 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n10http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q34246891
rdf:type
wikibase:Item
schema:description
мақолаи илмӣ 2003年学术文章 سائنسی مضمون vitskapeleg artikkel articol științific 2003年学术文章 2003年學術文章 2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ artículo científico publicado en 2003 teaduslik artikkel 2003年學術文章 artykuł naukowy scienca artikolo bilimsel makale bài báo khoa học artigo científico научни чланак artigo científico (publicado na 2003) vitenskapelig artikkel videnskabelig artikel (udgivet 2003) wetenschappelijk artikel 2003年学术文章 artikull shkencor artículu científicu espublizáu en 2003 научна статия 2003年学术文章 мақолаи илмӣ article scientifique (publié 2003) article científic 2003年學術文章 научни чланак vedecký článok מאמר מדעי ശാസ്ത്രപ്രബന്ധം​ vědecký článek article scientific articolo scientifico บทความทางวิทยาศาสตร์ tudományos cikk مقالة علمية 2003年學術文章 tieteellinen artikkeli наукова стаття, опублікована у вересні 2003 vetenskaplig artikel სამეცნიერო სტატია wissenschaftlicher Artikel 2003年學術文章 2003년 논문 artikulong pang-agham scientific article научная статья مقالهٔ علمی 2003年学术文章 mokslinis straipsnis 2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված artigo científico (publicado na 2003) 2003年學術文章 naučni članak 2003 nî lūn-bûn 2003年の論文 επιστημονικό άρθρο
p:P577
wds:Q34246891-62AFE058-8499-4498-90DE-BAEC0D7808D0
wdt:P577
2003-09-01T00:00:00Z
p:P407
wds:Q34246891-F2B5D834-7C69-414A-9E6A-DD5DBF781248
wdt:P407
wd:Q1860
p:P2860
wds:Q34246891-0124D004-D01D-44E9-8C08-49C8972E6553 wds:Q34246891-18585DF3-51E4-429A-95E6-38A4E3371A84 wds:Q34246891-E5E3D122-9747-4158-84DB-057B0CA92A3E wds:Q34246891-F6182F85-A5A5-4B27-A98D-DAC6C007E73F wds:Q34246891-DFB3ACE6-821C-497A-8CB9-AACBA408C01D wds:Q34246891-E19D952E-A0E2-4E22-9CFA-577DA5E5475D wds:Q34246891-2F917436-5CEE-46CC-9C1C-AF9ADF2BF451 wds:Q34246891-3027BFA9-969B-4440-8FB4-92BCB076CF3D wds:Q34246891-39E35D2B-D040-4A3C-9533-ABE8C2FE76E0 wds:Q34246891-2A01C579-09B6-4265-9A6A-8AC2FD41C449 wds:Q34246891-2C437AF3-0E7E-4E21-A48A-971DBA6B2C81 wds:Q34246891-3D95F3D1-F502-43DE-9D23-D6209B42F12B wds:Q34246891-83AD308B-3629-4A64-BD98-967849E80000 wds:Q34246891-A4B15726-EDC4-4EF9-B842-6317CEA86DBE wds:Q34246891-760742A3-BBBD-4A8C-A163-983EFF1D2ED3 wds:Q34246891-7B1122C7-A2E8-4398-BC99-CB29E3561356 wds:Q34246891-7E443D7C-2F4B-4763-8336-3982F73ACD85 wds:Q34246891-C8B28283-C476-4A02-810E-55CA2587D4A2 wds:Q34246891-B35BC93C-182E-4737-8F8F-D7F89EC1FFC6 wds:Q34246891-B3C5F27B-81F3-4CBB-8B47-D8C5EF39C069 wds:Q34246891-B4581244-E988-47B1-8001-55DB2674E7E6
wdt:P2860
wd:Q45165979 wd:Q44133527 wd:Q44473168 wd:Q34130575 wd:Q57396386 wd:Q43783255 wd:Q58975447 wd:Q74529466 wd:Q77782576 wd:Q73023637 wd:Q35125701 wd:Q43711832 wd:Q48118604 wd:Q34620874 wd:Q34516865 wd:Q43760028 wd:Q68452884 wd:Q73492524 wd:Q34246882 wd:Q40717823 wd:Q34106793
p:P2093
wds:Q34246891-189285EC-D873-4F79-AAFD-15B8AEF80D3A wds:Q34246891-2DB90277-3396-4D07-9A0E-55B2041197BE
wdt:P2093
Bertil Olofsson Jan Ostergren
rdfs:label
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
skos:prefLabel
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
schema:name
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
p:P50
wds:Q34246891-472B4270-8C61-4155-A5A2-67B8D5BDBF47 wds:Q34246891-2D0D8A70-A95C-49D5-92C3-DF630C5ED5B3 wds:Q34246891-00F849B9-CCDA-4C36-9496-1C8816BD2A73 wds:Q34246891-FBA9DBD2-2019-48D4-B651-55A5183B7863 wds:Q34246891-E0A1DBC0-42FB-4189-A8E3-F8A09AD2F60A wds:Q34246891-EC7FD9E8-7797-4B50-8731-3E2B8A738F27 wds:Q34246891-B6429684-151F-4613-BD9C-A88ECC1D4BC1 wds:Q34246891-AEB54FC9-7076-40AD-82D9-C15AAF1D31BE
wdt:P50
wd:Q114443546 wd:Q65769660 wd:Q112368936 wd:Q114321706 wd:Q2214381 wd:Q114427128 wd:Q56633150 wd:Q62050240
p:P1476
wds:Q34246891-46D7BB48-344A-405B-8ACB-72B1F2DE18E9
wdt:P1476
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial
p:P304
wds:Q34246891-6CD5B43E-5E53-4F5D-A4D6-FB5C1266DC11
wdt:P304
767-771
p:P31
wds:Q34246891-D2A13787-00F0-434E-B861-0C05C2ECDE15
wdt:P31
wd:Q13442814
p:P921
wds:Q34246891-56A5BB36-A286-445F-B2C3-15B719272733 wds:Q34246891-255A6475-0D0A-4BC4-ACE4-C208EE4E85A3 wds:Q34246891-C09A5887-7429-47F1-BB69-B37CB0EAA4AB wds:Q34246891-ADD6CC39-4F27-40EB-B2B9-51FDD1DAB0F9
wdt:P921
wd:Q11829287 wd:Q181754 wd:Q496359 wd:Q181600
p:P698
wds:Q34246891-DC234671-C46B-424F-8F41-9FD8434A9846
wdtn:P698
n11:13678869
wdt:P698
13678869
p:P1433
wds:Q34246891-7F7C2BCE-0164-4484-B914-7113C3617D49
wdt:P1433
wd:Q939416
p:P433
wds:Q34246891-4E399094-2B8A-442E-8A95-896ACAFABA0D
p:P478
wds:Q34246891-536C9CFE-C182-4F81-A0C1-3545D41EF5A8
wdt:P433
9386
wdt:P478
362
p:P356
wds:Q34246891-DE7D61CE-1C93-49B6-8017-3681C7C9D7E7
wdtn:P356
n10:S0140-6736(03)14283-3
wdt:P356
10.1016/S0140-6736(03)14283-3